Yakult Honsha Co Ltd
TSE:2267
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.6), the stock would be worth ¥3 054.48 (10% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.5 | ¥2 768.5 |
0%
|
| 3-Year Average | 1.6 | ¥3 054.48 |
+10%
|
| 5-Year Average | 1.9 | ¥3 581.3 |
+29%
|
| Industry Average | 0.7 | ¥1 332.63 |
-52%
|
| Country Average | 1.1 | ¥2 090.19 |
-25%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥718.9B
|
/ |
Jan 2026
¥485.2B
|
= |
|
|
¥718.9B
|
/ |
Mar 2026
¥490.3B
|
= |
|
|
¥718.9B
|
/ |
Mar 2027
¥505.2B
|
= |
|
|
¥718.9B
|
/ |
Mar 2028
¥517.5B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Yakult Honsha Co Ltd
TSE:2267
|
811.9B JPY | 1.5 | 21.1 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 23 896.4 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
205.8B CHF | 2.8 | 23.2 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
73.8B USD | 2.4 | 30.1 | |
| FR |
|
Danone SA
PAR:BN
|
43.3B EUR | 1.8 | 23.8 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
48.7B ZAR | 1.3 | 12.8 | |
| US |
|
Hershey Co
NYSE:HSY
|
38.8B USD | 3.7 | 44 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
237.6B CNY | 2.1 | 24.3 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
231.2B CNY | 6.8 | 32.8 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
32.7B ZAR | 2 | 12.7 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.8B CHF | 4.2 | 32.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2 |
| Max | 12 107 466 |
Other Multiples
Yakult Honsha Co Ltd
Glance View
Yakult Honsha Co., Ltd., a company rooted in Japanese tradition and scientific innovation, has become a global powerhouse in the probiotics industry. The journey began in 1935 when microbiologist Minoru Shirota pioneered the development of a fermented milk drink containing a unique strain of bacteria, Lactobacillus casei Shirota. This visionary endeavor aimed to improve gut health utilizing the principles of preventive medicine, a novel concept at the time. Yakult's flagship product, a small, iconic bottle of sweet-tasting probiotic milk, swiftly captured the attention and trust of Japanese consumers, setting the company on a trajectory of continuous growth and worldwide expansion. The company leveraged its strong research foundation to consistently innovate its product offerings, ensuring Yakult remained at the forefront of the health and wellness trend. In the modern marketplace, Yakult's operations exemplify a successful case of strategic internationalization. By maintaining a robust distribution network across more than 40 countries, the company effectively taps into varying health consciousness trends across diverse cultures. Revenue is primarily derived from the sales of its probiotic beverages, which are produced through a time-honored fermentation process. Yakult has strengthened its market position through direct sales strategies, including the hallmark “Yakult Ladies,” who personally deliver products to customers, enhancing consumer engagement and fostering brand loyalty. Beyond beverages, Yakult has diversified its portfolio to include cosmetics and pharmaceuticals, though the probiotic drinks remain its core profit engine. This diversification not only draws on the company's microbiological expertise but also mitigates risk by reducing dependency on a single product line.